Lin Y, Berdeja J, Raje N, et al. First-in-human multicenter study of BB2121 anti-BCMA CAR T cell therapy for relapsed/refractory multiple myeloma: updated results. EHA 2017, abstract 142.
Nieuw NGS-assay voorspelt overleving na CLL-behandeling
nov 2022 | Leukemie, MM